Product Program year 2024 Source: CMS Open Payments

Mitraclip

Device Vascular

PDI 08717648231025

Open in the dashboard

General payments

$3,647,157

12,472 payments

Research payments

$1,974,038

652 payments

Through program year 2024, $3,647,157 in general payments and $1,974,038 in research payments were reported against Mitraclip (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $1,895,377 3,586
2024 Research $88,000 2
2023 General $1,751,780 8,886
2023 Research $1,886,038 650

Breakdown

Who paid General payments · program years 2023–2024
  1. Abbott Laboratories $3,647,157 12,472 payments
Top recipients General payments · program year 2024
  1. St. Francis Hospital Teaching hospital · NY $81,600 4% · 1 payment
  2. Washington Hospital Center Teaching hospital · DC $75,000 4% · 1 payment
  3. Paul Sorajja Interventional Cardiology · Phoenix, AZ $74,489 4% · 40 payments
  4. Scripps Mercy Hospital Teaching hospital · CA $65,000 3% · 2 payments
  5. Lior Fortis Cardiovascular Disease · New York, NY $60,000 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $611,289 38% · 272 practitioners
  2. Cardiovascular Disease Internal Medicine $524,165 32% · 285 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $177,997 11% · 68 practitioners
  4. Advanced Heart Failure and Transplant Cardiology Internal Medicine $63,371 4% · 17 practitioners
  5. Anesthesiology $46,085 3% · 43 practitioners

The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $286,253 15% · 79 recipients
  2. New York $255,985 14% · 73 recipients
  3. Florida $188,324 10% · 71 recipients
  4. Ohio $118,344 6% · 46 recipients
  5. North Carolina $104,974 6% · 78 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

12,472 general · 652 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record